Tirzepatide Shows Powerful Diabetes-Prevention Effect

[skb]

Tirzepatide, a new injectable weight-loss drug with the trade name Zepbound, reduced the risk of diabetes in patients with obesity and prediabetes by more than 90% over a three-year period, compared with placebo, according to the results of a new study led by investigators at Weill Cornell Medicine, NewYork-Presbyterian, Yale School of Medicine and other institutions.

Read More ...

[skb]

The report that I have posted above is dated Nov 26th, 2024 but it does say that the study has been ongoing for 3 years.

Just this morning a report in the new paper said that this trial has been abandoned mid-way because of some liver complications that have been reported.   

[bigskygal]

The report that I have posted above is dated Nov 26th, 2024 but it does say that the study has been ongoing for 3 years.

Just this morning a report in the new paper said that this trial has been abandoned mid-way because of some liver complications that have been reported.   

Wow, good thing they caught that before it became the next Ozempic and really messed up a lot of people!! I have finally got my liver well on the road to recovery, I'd never want to end up somehow taking a med that ruined all that progress.